110 related articles for article (PubMed ID: 17543377)
1. Modifications to an Fcgamma-Fcvarepsilon fusion protein alter its effectiveness in the inhibition of FcvarepsilonRI-mediated functions.
Allen LC; Kepley CL; Saxon A; Zhang K
J Allergy Clin Immunol; 2007 Aug; 120(2):462-8. PubMed ID: 17543377
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
[TBL] [Abstract][Full Text] [Related]
4. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
5. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of an Fcgamma-Fc(epsilon)-fusion protein in house dust mite sensitive nonhuman primates.
Van Scott MR; Mertsching E; Negrou E; Miles J; Stallings HW; Graff C; Kehry MR
Clin Immunol; 2008 Sep; 128(3):340-8. PubMed ID: 18583194
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
9. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
10. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
[TBL] [Abstract][Full Text] [Related]
11. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
[TBL] [Abstract][Full Text] [Related]
12. Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.
Zhang K; Zhu D; Kepley C; Terada T; Saxon A
Immunol Allergy Clin North Am; 2007 Feb; 27(1):93-103. PubMed ID: 17276881
[TBL] [Abstract][Full Text] [Related]
13. The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses.
Moñino-Romero S; Erkert L; Schmidthaler K; Diesner SC; Sallis BF; Pennington L; Jardetzky T; Oettgen HC; Bohle B; Fiebiger E; Szépfalusi Z
Allergy; 2019 Feb; 74(2):236-245. PubMed ID: 30030936
[TBL] [Abstract][Full Text] [Related]
14. Improved FcγRIIb targeting functionally translates into enhanced inhibition of basophil activation.
Buschor P; Eggel A; Zellweger F; Stadler BM; Vogel M
Int Arch Allergy Immunol; 2014; 163(3):206-14. PubMed ID: 24557487
[TBL] [Abstract][Full Text] [Related]
15. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site.
Sandomenico A; Monti SM; Marasco D; Dathan N; Palumbo R; Saviano M; Ruvo M
Mol Immunol; 2009 Oct; 46(16):3300-9. PubMed ID: 19699527
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of sesquiterpene lactones isolated from Eupatorium chinense L. on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice.
Itoh T; Oyama M; Takimoto N; Kato C; Nozawa Y; Akao Y; Iinuma M
Bioorg Med Chem; 2009 Apr; 17(8):3189-97. PubMed ID: 19318257
[TBL] [Abstract][Full Text] [Related]
17. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation.
Nakano N; Nishiyama C; Tokura T; Nagasako-Akazome Y; Ohtake Y; Okumura K; Ogawa H
Int Arch Allergy Immunol; 2008; 147(3):213-21. PubMed ID: 18594151
[TBL] [Abstract][Full Text] [Related]
18. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
19. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway.
Oliver JM; Kepley CL; Ortega E; Wilson BS
Immunopharmacology; 2000 Jul; 48(3):269-81. PubMed ID: 10960668
[TBL] [Abstract][Full Text] [Related]
20. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.
Tsujimura Y; Obata K; Mukai K; Shindou H; Yoshida M; Nishikado H; Kawano Y; Minegishi Y; Shimizu T; Karasuyama H
Immunity; 2008 Apr; 28(4):581-9. PubMed ID: 18342553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
